Complement dependency of cardiomyocyte release of mediators during sepsis

FASEB Journal

Volumn 25, Issue 7, 2011, Pages 2500-2508

  Atefi, Gelareh ^a   Zetoune, Firas S ^a   Herron, Todd J ^a   Jalife, José ^a   Bosmann, Markus ^a   Al Aref, Rami ^a   Sarma, J Vidya ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

C5a; Cardiomyopathy; Cytokine receptors; Cytokines; IL 17A

Indexed keywords

CHEMOKINE; COMPLEMENT COMPONENT C5A; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; MALE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL;

ANIMALS; CHEMOKINE CCL3; CHEMOKINE CXCL2; CHEMOKINES; COMPLEMENT C5A; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

MUS; RATTUS;

EID: 79960196840     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-183236     Document Type: Article

References (30)

1. Rabuel, C., and Mebazaa, A. (2006) Septic shock: a heart story since the 1960s. Intensive Care Med. 32, 799-807 (Pubitemid 43781360)
2. Clowes, G. H., Jr., Vucinic, M., and Weidner, M. G. (1966) Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases. Ann. Surg. 163, 866-885
3. Babuin, L., and Jaffe, A. S. (2005) Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173, 1191-1202 (Pubitemid 41637819)
4. Rittirsch, D., Flierl, M. A., and Ward, P. A. (2008) Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776-787
5. Parrillo, J. E., Burch, C., Shelhamer, J. H., Parker, M. M., Natanson, C., and Schuette, W. (1985) A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J. Clin. Invest. 76, 1539-1553 (Pubitemid 16193573)
6. Crouser, E. D. (2004) Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4, 729-741
7. Gellerich, F. N., Trumbeckaite, S., Opalka, J. R., Gellerich, J. F., Chen, Y., Neuhof, C., Redl, H., Werdan, K., and Zierz, S. (2002) Mitochondrial dysfunction in sepsis: evidence from bacteraemic baboons and endotoxaemic rabbits. Biosci. Rep. 22, 99-113 (Pubitemid 35217482)
8. Brealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., Davies, N. A., Cooper, C. E., and Singer, M. (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360, 219-223 (Pubitemid 34804650)
9. Harrois, A., Huet, O., and Duranteau, J. (2009) Alterations of mitochondrial function in sepsis and critical illness. Curr. Opin. Anaesthesiol. 22, 143-149
10. Flierl, M. A., Rittirsch, D., Huber-Lang, M. S., Sarma, J. V., and Ward, P. A. (2008) Molecular events in the cardiomyopathy of sepsis. Mol. Med. 14, 327-336
11. Joulin, O., Petillot, P., Labalette, M., Lancel, S., and Neviere, R. (2007) Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol. Res. 56, 291-297
12. Cain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Joo, K. S., Banerjee, A., and Harken, A. H. (1999) Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit. Care Med. 27, 1309-1318
13. Janssen, S. P., Gayan-Ramirez, G., Van den Bergh, A., Herijgers, P., Maes, K., Verbeken, E., and Decramer, M. (2005) Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111, 996-1005 (Pubitemid 40354517)
14. Kumar, A., Paladugu, B., Mensing, J., and Parrillo, J. E. (2007) Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum. Crit. Care Med. 35, 358-364
15. Maass, D. L., White, J., and Horton, J. W. (2002) IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock 18, 360-366
16. Maass, D. L., Hybki, D. P., White, J., and Horton, J. W. (2002) The time course of cardiac NF-kappaB activation and TNF-alpha secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac contractile dysfunction. Shock 17, 293-299
17. Niederbichler, A. D., Hoesel, L. M., Westfall, M. V., Gao, H., Ipaktchi, K. R., Sun, L., Zetoune, F. S., Su, G. L., Arbabi, S., Sarma, J. V., Wang, S. C., Hemmila, M. R., and Ward, P. A. (2006) An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J. Exp. Med. 203, 53-61
18. Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., and Ward, P. A. (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4, 31-36
19. Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Riedemann, N. C., Younger, J. G., and Ward, P. A. (2001) Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J. 15, 568-570
20. Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Kohl, J., Gerard, C., Sarma, J. V., and Ward, P. A. (2008) Functional roles for C5a receptors in sepsis. Nat. Med. 14, 551-557
21. Flierl, M. A., Rittirsch, D., Gao, H., Hoesel, L. M., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huber-Lang, M. S., Ferrara, J. L., and Ward, P. A. (2008) Adverse functions of IL-17A in experimental sepsis. FASEB J. 22, 2198-2205
22. Herron, T. J., Vandenboom, R., Fomicheva, E., Mundada, L., Edwards, T., and Metzger, J. M. (2007) Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes. Circ. Res. 100, 1182-1190
23. Singh, M. V., Kapoun, A., Higgins, L., Kutschke, W., Thurman, J. M., Zhang, R., Singh, M., Yang, J., Guan, X., Lowe, J. S., Weiss, R. M., Zimmermann, K., Yull, F. E., Blackwell, T. S., Mohler, P. J., and Anderson, M. E. (2009) Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J. Clin. Invest. 119, 986-996
24. Ward, P. A. (2009) The sepsis seesaw: seeking a heart salve. Nat. Med. 15, 497-498
25. Buras, J. A., Rice, L., Orlow, D., Pavlides, S., Reenstra, W. R., Ceonzo, K., and Stahl, G. L. (2004) Inhibition of C5 or absence of C6 protects from sepsis mortality. Immunobiology 209, 629-635
26. Soriano, F. G., Nogueira, A. C., Caldini, E. G., Lins, M. H., Teixeira, A. C., Cappi, S. B., Lotufo, P. A., Bernik, M. M., Zsengeller, Z., Chen, M., and Szabo, C. (2006) Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit. Care Med. 34, 1073-1079
27. Pacher, P., and Szabo, C. (2007) Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc. Drug Rev. 25, 235-260 (Pubitemid 47547464)
28. Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., and Ward, P. A. (1999) Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788-792
29. Ballard-Croft, C., Carlson, D., Maass, D. L., and Horton, J. W. (2004) Burn trauma alters calcium transporter protein expression in the heart. J. Appl. Physiol. 97, 1470-1476
30. Thompson, M., Kliewer, A., Maass, D., Becker, L., White, D. J., Bryant, D., Arteaga, G., Horton, J., and Giroir, B. P. (2000) Increased cardiomyocyte intracellular calcium during endotoxin-induced cardiac dysfunction in guinea pigs. Pediatr. Res. 47, 669-676 (Pubitemid 30249858)